HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 283 filers reported holding HORIZON THERAPEUTICS PUB L in Q4 2019. The put-call ratio across all filers is 0.76 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $90,701 | +11.9% | 784 | -0.5% | 0.01% | +12.5% |
Q2 2023 | $81,046 | -6.8% | 788 | -1.1% | 0.01% | -11.1% |
Q1 2023 | $86,985 | -4.1% | 797 | 0.0% | 0.01% | -10.0% |
Q4 2022 | $90,699 | +248.8% | 797 | +90.7% | 0.01% | +233.3% |
Q3 2022 | $26,000 | -35.0% | 418 | -16.1% | 0.00% | -40.0% |
Q2 2022 | $40,000 | -16.7% | 498 | +10.2% | 0.01% | -16.7% |
Q1 2022 | $48,000 | -12.7% | 452 | -12.2% | 0.01% | -14.3% |
Q4 2021 | $55,000 | +27.9% | 515 | +29.7% | 0.01% | +16.7% |
Q3 2021 | $43,000 | +30.3% | 397 | +13.4% | 0.01% | +20.0% |
Q2 2021 | $33,000 | +50.0% | 350 | +44.6% | 0.01% | +25.0% |
Q1 2021 | $22,000 | +175.0% | 242 | +124.1% | 0.00% | +300.0% |
Q4 2020 | $8,000 | -75.0% | 108 | -73.5% | 0.00% | -85.7% |
Q3 2020 | $32,000 | +1500.0% | 407 | +971.1% | 0.01% | – |
Q2 2020 | $2,000 | -97.3% | 38 | -98.5% | 0.00% | -100.0% |
Q1 2020 | $73,000 | -17.0% | 2,472 | +1.1% | 0.01% | +9.1% |
Q4 2019 | $88,000 | +33.3% | 2,445 | +0.2% | 0.01% | +10.0% |
Q3 2019 | $66,000 | – | 2,440 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |